RxSight, Inc. Share Price & Technical Analysis
RXST · $6.08 (-4.25%)
Healthcare / Medical Devices
$6.08
-4.25%
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjus…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
-14% return in May, 17% avg return in past 3 year May month.
-45% return in 2026, 17% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -18% | -14% | -14% | 15% | -14% | – | – | – | – | – | – | – | -45% |
| 25 | -2% | -15% | -12% | -42% | 3% | -15% | -40% | 17% | -1% | -2% | 30% | -8% | -88% |
| 24 | 15% | 17% | -6% | 2% | 11% | 3% | -23% | 23% | -12% | 2% | -8% | -26% | -3% |
| 23 | 9% | -3% | 22% | 7% | 37% | 19% | 17% | -12% | -4% | -21% | 36% | 34% | 141% |
| 22 | -8% | 29% | -9% | -1% | 10% | 3% | 6% | -16% | -3% | 1% | 2% | -2% | 12% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$227.27M
P/E ratio
—
52W high
$16.48
52W low
$5.30
Volume
3,99,314
Beta
1.24
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is RxSight, Inc. share price today?
- RxSight, Inc. (RXST) last traded around $6.08 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does RXST have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for RXST. Download the app for real-time alerts.
- How can I analyze RxSight, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.